Corporate Europe Observatory

Exposing the power of corporate lobbying in the EU

  • Dansk
  • NL
  • EN
  • FI
  • FR
  • DE
  • EL
  • IT
  • NO
  • PL
  • PT
  • RO
  • SL
  • ES
  • SV

European Ombudsman demands EFSA admits failure over revolving door

Munich/ Brussels, 8 December 2011: The European Ombudsman has ruled in favour of a complaint filed by Testbiotech against the European Food Safety Authority (EFSA) regarding its approach to the 'revolving door'. The case concerns a former senior staff member at EFSA, Dr Suzy Renckens, who was head of the unit responsible for the risk assessment of genetically engineered plants for five years until 2008. Dr Renckens, a Belgian national, then moved to a job at Syngenta, a company that produces and markets these plants. The European Ombudsman has now agreed with Testbiotech's complaint and ruled that “EFSA should acknowledge that it failed to observe the relevant procedural rules and to carry out a sufficiently thorough assessment of the potential conflict of interests arising from the move of a former member of its staff to a biotechnology company”[1]. 

“The ruling from the Ombudsman shows in detail that EFSA failed to fulfill its obligations,” said Christoph Then from Testbiotech. “We are very concerned that both EFSA and the Commission have tried to deny their responsibilities in this case by rejecting our original complaints. The authority and the European Commission, which backs EFSA, are eroding confidence in European institutions. In consequence they are putting at risk the protection of consumers and the environment.”

Olivier Hoedeman from Corporate Europe Observatory said: “There have been other cases of staff going through the revolving door; EFSA should look carefully at the ruling and introduce a far stricter approach to conflicts of interest in the future. The Ombudsman makes some important recommendations which should lead to changes in how revolving door rules are implemented across the EU institutions, including at the Commission. We continue to see further scandalous revolving doors cases [2] and it is vital that the EU institutions, starting with the Commission, put improved rules and procedures in place to prevent future conflicts of interest, including a cooling off period of several years. It is time for a new start. No more business as usual.”

The Suzy Renckens case was made public by Testbiotech in November 2009 and the complaint was supported by Corporate Europe Observatory (CEO), Friends of the Earth Europe (FoEE) and Lobbycontrol (in Germany)[3]. EFSA now has until 31 March 2012 to respond to the judgement of the EU Ombudsman who has the power to table the issue in the European Parliament.

ENDS

Contact:

Testbiotech: Christoph Then, Tel +49 15154638040, info@testbiotech.org

CEO: Vicky Cann, Corporate Europe Observatory, tel: +32 28 93 09 30, mobile: +32 489 596 478

Notes:

[1] A link to the full ruling from the European Ombudsman can be found here: http://www.testbiotech.de/en/node/588

[2] CEO's RevolvingDoorWatch was launched on 7 December and it presents details of many other revolving door cases, including other cases at EFSA, and others concerning food industry lobbyists: http://www.corporateeurope.org/projects/revolvingdoorwatch

[3] All documents related to this complaint can be found here: http://www.testbiotech.de/independence

Related issues: 
 

CEO's reaction to the the Bahamas leaks, which revealed ex-EU competition commissioner Neelie Kroes' offshore links.

The Juncker Commission last week informed the European Ombudsman that it would refer Barroso’s appointment as chairman of Goldman Sachs to its Ad hoc Ethical Committee. But what is the Ad hoc Ethical Committee, who sits on it and what is it likely to say?

Corporate Europe Observatory welcomes the results of the European Ombudsman's investigation into the Commission's handling of the revolving doors and promised a further investigation into the Commission's approach.

Corporate Europe Observatory's media reaction to the European Commission referring its former president Barroso's Goldman Sachs appointment to an ethics committee.

Ahead of the Commission's proposal for a new ‘mandatory’ lobby transparency register, CEO takes a look at the summary of the public consultation on the subject: civil society's call for better transparency systems faces the spin of corporate lobby groups and trade associations, which appear to promote transparency values but recommend limited implementation, loopholes and toothless management.

CEO's reaction to the the Bahamas leaks, which revealed ex-EU competition commissioner Neelie Kroes' offshore links.

The European Commission's upcoming regulation proposal for acrylamide, a dangerous contaminant formed in many starchy foods when cooked at high temperatures, relies on codes of best practices developed by food industry lobby groups.

A new report on the Comprehensive Economic Trade Agreement (CETA) reveals how the trade deal could make EU member states vulnerable to costly lawsuits from North American investors that threaten public interest.

 
 
 
 
 
-- placeholder --
 
 
 

The corporate lobby tour